AI assistant
Sending…
Pulmonx Corp — Director's Dealing 2022
Dec 1, 2022
34428_dirs_2022-12-01_7389f0e2-412e-47fe-84ae-57691fc44b41.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2022-11-29
Reporting Person: Lynch Alissa Hsu (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-29 | Common Stock | P | 1700 | $5.51 | Acquired | 11910 | Direct |
More from Pulmonx Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 4
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2025
Dec 11
Director's Dealing
2025
Dec 9
Regulatory Filings
2025
Dec 9
Director's Dealing
2025
Dec 4
Director's Dealing
2025
Dec 4